Can terbinafine (Lamisil) and atorvastatin (Lipitor) be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Lamisil and Lipitor Be Taken Together?

Yes, terbinafine (Lamisil) and atorvastatin (Lipitor) can be taken together safely—there is no clinically significant drug interaction between these medications.

Key Evidence

The FDA labeling for Lipitor 11 specifically identifies drugs that require dose modifications or are contraindicated due to CYP3A4 interactions. Terbinafine is notably absent from this list. The contraindicated drugs include cyclosporine, gemfibrozil, tipranavir plus ritonavir, and glecaprevir plus pibrentasvir. Dose limitations are specified only for certain antivirals (saquinavir/ritonavir, darunavir/ritonavir, fosamprenavir, elbasvir/grazoprevir, letermovir, nelfinavir), azole antifungals (itraconazole), and macrolide antibiotics (clarithromycin).

The American Heart Association's 2016 guideline on statin drug interactions 2 comprehensively addresses clinically significant interactions with cardiovascular medications but does not mention terbinafine as a concern with atorvastatin.

Why This Combination Is Safe

Terbinafine has minimal drug interaction potential compared to azole antifungals. While azoles like itraconazole and fluconazole are potent CYP3A4 inhibitors (the enzyme that metabolizes atorvastatin), terbinafine primarily inhibits CYP2D6, not CYP3A4 34. This mechanistic difference is crucial—atorvastatin's metabolism occurs via CYP3A4, so terbinafine does not interfere with its breakdown.

Real-world evidence supports this safety profile. A large postmarketing surveillance study of 25,884 patients taking terbinafine found that 42.8% were on concomitant medications, including lipid-lowering agents, with no new drug interactions identified 53.

Clinical Monitoring

While no dose adjustment is needed, standard monitoring for both medications should continue:

  • For Lipitor: Monitor for muscle symptoms (pain, tenderness, weakness), particularly with fever or malaise, as myopathy risk exists with all statins 11
  • For Lamisil: Monitor liver function if clinically indicated, as both medications can rarely affect hepatic enzymes
  • No additional monitoring is required specifically for the combination

Important Caveat

Do not confuse terbinafine with azole antifungals. If a patient were taking itraconazole instead of terbinafine, atorvastatin would need to be limited to 20 mg daily 1. This is a common prescribing error to avoid.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.